Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-08-09
2011-08-09
Dunston, Jennifer (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S024300, C536S023500
Reexamination Certificate
active
07993826
ABSTRACT:
The present invention relates to a method for investigating body fluids for cancer cells, the use thereof and corresponding analysis kits, and the possibilities for cancer treatment derived therefrom. The method is based essentially on determining the expression of the manganese superoxide dismutase, thioredoxin reductase and/or glutathione peroxidase genes. Use of this method permits in particular reliable tumor diagnosis and prognosis. Diminishing an elevated expression of these genes has therapeutic value and may be utilized for cancer treatment.
REFERENCES:
patent: 5246847 (1993-09-01), Hartman et al.
patent: 5260204 (1993-11-01), Heckl et al.
patent: 5985633 (1999-11-01), Nick et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2003/0157581 (2003-08-01), Grill et al.
patent: 2301962 (1999-03-01), None
patent: 2338751 (2000-02-01), None
patent: 100 54 632 (2002-05-01), None
patent: WO 96/29430 (1996-09-01), None
patent: WO 02/18634 (2002-03-01), None
Boer et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Research, vol. 11, No. 11, pp. 1861-1870, 2001.
Entry for 1.15.1.1, printed from http://us/expasy.org/enzyme on May 5, 2008.
Pusztai and Hess. Clinical trial design for microarray predictive marker discovery and assessment. Annals of Oncology, vol. 15, pp. 1731-1737, 2004.
Kroese et al. Genetic tests and their evaluation: Can we answer the key questions? Genetics in Medicine, vol. 6, pp. 475-480, 2004.
Golub et al. Molecular classification of cancer: Class discovery and class predictaion by gene expression monitoring. Science, Bol. 286, pp. 531-537, Oct. 1999.
Entrez Gene entry for SOD2 [Homo sapeins], printed from http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene on May 5, 2008.
Entrez Gene entry for TXNRD1 [Homo sapiens], printed from http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene on May 5, 2008.
Entrez Gene entry for GPX1 [Homo sapiens], printed from http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene on May 5, 2008.
Seven et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clinical Biochemistry, vol. 32, No. 5, pp. 369-373, 1999.
Kizaki et al. Regulation of manganese superoxide dismutase and other antioxidant genes in normal and leukemic hematopoietic cells and their relationship to cytotoxicity by tumor necrosis factor. Blood, vol. 82, No. 4, pp. 1142-1150, Aug. 1993.
GEO entry for platform GPL10, description and entry for thioredoxin reductase only, printed from http://www.ncbi.nlm.nih.gov/geo/ on Apr. 29, 2008.
Giesing et al. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy BJU International, DOI:10.1111/j.1464-410X.2009.08920.x , published online Oct. 10, 2009.
Sarto, C., et al., “Modified Expression of Plasma Glutathione Peroxidase and Manganese Suieroxide Dismutase in Human Renal Cell Carcinoma”, Electrophoresis 1999, 20, 3458-3466.
Mork, H., et al., “Inverse mRNA Expression of the Selenocysteine-Containing Proteins GI-GPx and SeP Colorectal Adenomas Compared With Adjacent Normal Mucosa”, Nutrition and Cancer, 37(1), 108-116, 2000.
Sarto, C., et al., “Renal Cell Carcinoma and Normal Kidney Protein Expression”, Electrophoresis 1997, 18, 599-604.
Gladyshev, V.N., et al., “Contrasting Patterns of Regulation of the Antioxidant Selenoproteins, Thioredoxin Reductase, and Glutathione Peroxidase, in Cancer Cells”, Biochemical and Biophysical Research Communications, 251, 488-493 (1998) Article No. RC989495.
Bravard, A., et al., “Modifications of the Antioxidant Enzymes in Relation to Chromosome Imbalances in Human Melanoma Cell Lines”, Melanoma Research 1998, 8, pp. 329-335.
Peskin, A. V., et al., “Superoxide Dismutase and Glutathione Peroxidase Activities in Tumors”, FEBS Letters, vol. 78, No. 1, Jun. 1977, 41-45.
Kahlos, K., et al., “Manganese Superoxide Dismutase in Healthy Human Pleural Mesothelium and in Malignant Pleural Mesothelioma”, Am. J. Respir. Cell Mol. Biol., vol. 18, pp. 570-580, 1998.
Dvorakova, K., “Molecular and Celular Characterization of Imexon-Resistant RPMI8226/I Myeloma Cells1”, Molecular Cancer Therapeutics, vol. 1, p. 185-195, Jan. 2002.
Asikainen, T.M., et al., “Expression and Developmental Profile of Antioxidant Enzymes in Human Lung and Liver”, A. J. Respir. Cell Mol. Biol., vol. 19, pp. 942-949, 1998.
Li, Z., et al., “Genes Regulated in Human Breast Cancer Cells Overexpressing Manganese-Containing Superoxide Dismutase”, Free Radical Biology & Medicine, vol. 30, No. 3, pp. 260-267, 2001.
Mercatante, K.R., et al., “Control of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy: Effects on Gene Expression”, Biochem & Biophys Acta, Jul. 18, 2002, 1587 (2-3): 126-132.
Janssen, AML, et al., “Superoxide Dismutases in Relation to the Overall Survival of Colorectal Cancer Patients”, British Journal of Cancer (1998) 78(8), 1051-1057.
Janseen, AML, et al., “Superoxide Dismutases in Gastric and Esophageal Cancer and the Prognostic Impact in Gastric Cancer1”, Clinical Cancer Research, vol. 6, 3183, Aug. 2000.
Ria, F., et al., “The Level of Manganese Superoxide Dismutase Content is an Independent Prognostic Factor for Glioblastoma Biological Mechanisms and Clinical Implications”, British Journal of Cancer (2001) 84(4), 529-534.
Giesing, M., et al., “Independent Prognostication and Therapy Monitoring of Breast Cancer Patients by DNA/RNA typing of Minimal Residual Cancer Cells”, The International Journal of Biological Markers, vol. 15, No. 1, pp. 94-99, 2000.
Barra, D., et al., “The Primary Structure of Human Liver Manganese Superoxide Dismutase”, The Journal of Biological Chemistry, vol. 259, No. 20, Issue of Oct. 25, 12595-12601, 1984.
“GeneChip® Human Genome U133 Set, Comprehensive Coverage of All Well-Substantiated Genes in the Human Genome”, Gene Expression Monitoring, Affymetrix, printed Jan. 21, 2002, pp. 1-2.
Stoehlmacher, J., et al, “The -9 Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma”, Oncol. Rep., Mar.-Apr. 2002, 9(2):235-8 (Abstract).
Forsberg, L., et al., “Low yield of polymorphisms from EST blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1”, Hum. Mutat. 1999, 13(4):294-300 (Abstract).
Li, S., et al., “The Role of Cellular Glutathione Peroxidase Redox Regulation in the Suppression of Tumor Cell Growth by Manganese Superoxide Dismutase1”, Cancer Research 60, 3927-3939, Jul. 15, 2000 (Abstract).
Soderberg, A., et al., “Thioredoxin Reductase, a Redox-active Selenoprotein, Is Secreted by Normal and Neoplastic Cells: Presence in Human Plasma1”, Cancer Research 60, 2281-2289, Apr. 15, 2000 (Abstract).
Becker, K., et al. “Thioredoxin reductase as a pathophysiological factor and drug target”, Eur. J. Biochem. 267, 6118-6125 (2000) (Abstract).
Soini, Y., et al., “MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells”, J. Pathol. Sep. 2001, 195(2):156-62 (Abstract).
Chung-Man, H.J., et al., “Differential expression of manganese superoxide dismutase and catalase in lung cancer”, Cancer Res 2001, Dec. 1, 61(23):8578-85 (Abstract).
Janssen, A.M., et al., “Superoxide dismutases in the human colorectal cancer sequence”, J. Cancer Res. Clin. Oncol., 1999, 125(6):327-35 (Abstract).
Oberley, L.W., “Anticancer the
Giesing Michael
Suchy Bernhard
Bacon & Thomas PLLC
Dunston Jennifer
Giesing Michael
LandOfFree
Method for analyzing blood for the presence of cancer cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for analyzing blood for the presence of cancer cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for analyzing blood for the presence of cancer cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2677110